pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›IBANDRONATE SODIUM
drug · small molecule
save

IBANDRONATE SODIUM

Marketedupdated 5mo ago
by $RDY DR REDDYS LABORATORIES LTD🔗 ChEMBL
Approved
community read0 votes

🐶 often sniffed alongside

top 3
  • tagApproval138 co-mentions · 69 sources
  • tagSmall Molecule40 co-mentions · 40 sources
  • companyAurobindo Pharma Ltd3 co-mentions · 3 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 1 investigational indication.

targets

Farnesyl pyrophosphate synthase

all catalysts(36)

approval · 36
Mar 19, 2012
approval
15y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Apr 30, 2012
approval
$RDY12.58+2.69%
14y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Aug 15, 2012
approval
14y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Mar 8, 2013
approval
$RDY12.58+2.69%
14y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 15, 2015
approval
$RDY12.58+2.69%
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 15, 2015
approval
$RDY12.58+2.69%
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 22, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 22, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 22, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 24, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 24, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 24, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 16, 2015
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 5, 2016
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Mar 11, 2016
approval
11y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 31, 2017
approval
9y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Dec 12, 2019
approval
7y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Dec 17, 2019
approval
7y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jun 19, 2020
approval
$RDY12.58+2.69%
6y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 22, 2022
approval
5y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jun 7, 2023
approval
3y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jun 23, 2023
approval
3y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 19, 2023
approval
$RDY12.58+2.69%
3y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 19, 2023
approval
$RDY12.58+2.69%
3y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 27, 2023
approval
3y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 11, 2024
approval
2y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Oct 8, 2024
approval
2y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Jul 25, 2025
approval
1y ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
$RDY12.58+2.69%
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
Feb 3, 2026
approval
8mo ago
IBANDRONATE SODIUM — FDA approval
IBANDRONATE SODIUM
→
view all 36 catalysts →

News(0)

no news has mentioned this drug yet

brand
IBANDRONATE SODIUM
trade names
Bondenza (previously ibandronic acid roche), Bondronat, Boniva, Bonviva, Destara, Iasibon
generic
IBANDRONATE SODIUM
MOA
12.1 Mechanism of Action The action of ibandronate on bone tissue is based on its affinity for hydroxyapatite, which is part of the mineral matrix of bone. Ibandronate inhibits osteoclast activity and reduces bone resorption and turnover. In postmenopausal women, it reduces the elevated rate of bone turnover, leading to, on average, a net gain in bone mass.
phase
marketed
Data sources
openFDA · ClinicalTrials.gov · OpenTargets
last refreshed 16m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?